Outcomes of Corticosteroids Combined with 15 Mg/Week Methotrexate as Initial Treatment for Acute Vogt-Koyanagi-Harada Disease
Initial treatments with corticosteroids tapered over approximately 9 months and oral methotrexate (15 mg/week) for 18 months in acute VKH patients led to favorable visual outcomes, fairly low recurrence and good safety profile. These findings support the consideration of this combined treatment for acute VKH but should be tempered by recognizing the retrospective and non-control design.
Authors
- Yuan Pan (ORCID: https://orcid.org/0000-0002-4058-1538)
- Dan Liang (ORCID: https://orcid.org/0000-0002-7617-0204)
- Xiaohong Chen (ORCID: https://orcid.org/0000-0002-9797-8384)
- Yuxi Chen (ORCID: https://orcid.org/0000-0001-9450-8793)
- Yao Lu (ORCID: https://orcid.org/0000-0001-9004-9569)
- Yanyan Xie (ORCID: https://orcid.org/0009-0004-6957-8131)
- Yiwen Xia
Institutions
- Sun Yat-sen University (CN)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1080/09273948.2025.2464716
- Citations
- 1
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- National Natural Science Foundation of China